AzTrials
AzTrials

Vaccination BehaviorNCT07141875

Child Vaccination Scheduling in China

An observational study of Vaccination Behavior, run by Peking University at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to optimize pediatric vaccine scheduling in China . The first objective is to gather information on current vaccine schedules in China. The second objective is to evaluate the impact of simultaneous vaccination and combination vaccines on costs and vaccination rates through feedback from caregivers and… Read more about this study

Who is it for?
Ages 2 months and olderHealthy volunteers can take part
Conditions the study is for
Vaccination Behavior
Type of treatment
Vaccines
How many people
6,000 participants
Where
1 siteChina
Study dates
25 Aug 2025to 30 Oct 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 months and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The sample will consist of 6,000 caregivers of children (aged between 2 to 59 months) from 10 representative provinces/municipalities/autonomous regions as well as Vaccination and health care personnel in each study site.

Who may be able to join

  • For caregivers of children
  • Children aged ≥2 months and ≤59 months
  • Caregivers informed consent obtained For vaccination staff
  • All vaccination staff currently working at the selected community health service centers or township health clinics on the day of the survey For retrospective analysis
  • Children aged 5 years and under; with complete vaccination records. Complete vaccination records refer to a child having received all vaccines required by the NIP for their age group, with accurate dates recorded for each vaccination dose.

Who cannot join

  • For caregivers of children
  • Caregivers who are unable to participate in the survey due to physical or other objective reasons
  • Caregivers with communication barriers
  • Caregivers who do not consent to participate in the survey For vaccination staff
  • Vaccination staff who do not consent to participate in the survey For retrospective analysis
  • Children whose vaccination records are missing or incomplete
  • Children whose vaccination has been delayed or not received due to medical contraindications.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Peking University Health Science Center

    Beijing, Beijing Municipality, 100191

Other trials in China

About this study

Official title: Optimization Strategies for Pediatric Vaccination Scheduling in China: The Impact of Local Policies, Caregivers, Vaccination Staff, and the Cost-Effectiveness of Simultaneous and Combined Vaccinations

This study aims to optimize pediatric vaccine scheduling in China . The first objective is to gather information on current vaccine schedules in China. The second objective is to evaluate the impact of simultaneous vaccination and combination vaccines on costs and vaccination rates through feedback from caregivers and vaccination staff.

Read the detailed description

The first objective will comprehensively collect vaccination programs for children under 6 years old in all 31 provinces of China (excluding Hong Kong, Macau, and Taiwan), covering both NIP and non-NIP vaccines that are suitable for children. The second objective is to evaluate the impact of simultaneous vaccination and combination vaccines on costs and vaccination rates. This will involve analyzing vaccination coverage for simultaneous vaccines across different regions in China, as well as assessing caregivers' perspectives on simultaneous vaccination, including their willingness, preferences, and factors influencing their vaccination decisions. Additionally, the study will explore vaccination staff attitudes, recommendation behaviors, and their reasons for recommending simultaneous and combination vaccines. For the survey, the sample will consist of caregivers of children (aged between 2 to 59 months) from 10 representative provinces/municipalities/autonomous regions as well as vaccination staff from institutions in the respective regions.

Being tested
No intervention
Keywords
Children vaccine, Simultaneous vaccination, Combination vaccines

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    This is an observational study without any interventions.

Study groups in NCT07141875
Study groupRoleWhat they receive
• Caregiver of ChildrenInterviewees are parents or grandparents of children aged between 6 to 59 months.
Receives: Other: No intervention
Vaccination and health care personnelInterviewees are vaccination and health care personnel in each study site.
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The economic value of optimized vaccination scheduling strategies

    This study will comprehensively collect vaccination programs for children under 6 years old in all 31 provinces of China (excluding Hong Kong, Macau, and Taiwan), covering both NIP and non-NIP vaccines that are suitable for children.

    The economic value of optimized vaccination scheduling strategies with simultaneous vaccination and combination vaccines will be assessed using a cost-minimization and budget impact model with inputs collected in this study. The optimized vaccination scheduling strategie will be collected in this study through a literature review, a cross-sectional caregiver survey, a survey among vaccination staff, and an observational time and motion chart among the latter population.

    Measured: 2025.08-2025.09

  2. Caregivers' willingness to simultaneous vaccination and combined vaccines

    To evaluate the acceptance and willingness of different vaccination strategies, the survey will collect caregivers' knowledge, attitudes, and preferences on optimized vaccine scheduling strategies including simultaneous vaccination and combination vaccines, as well as factors influencing their decisions , such as the vaccination status of siblings of other children and elderly family members over 60 years old. The primary outcome variable will be willingness to simultaneous vaccination and combined vaccines, assessed using a 5-point ordinal scale (from "very unwilling" to "very willing").

    Measured: 2025.08-2025.09

  3. Immunization records and vaccination coverage

    Using data collected from children's immunization records, a retrospective analysis will explore how previous simultaneous vaccination behaviors affect their vaccination rate. By comparing the vaccination rates at different ages between children receiving vaccines concomitantly vs. separately and children who uses combination vaccines vs. single vaccines, the study will evaluate whether the optimized vaccine scheduling strategies including simultaneous vaccination and combination vaccines have an impact on children's vaccination coverage.

    Measured: 2025.08-2025.09

Secondary outcomes (2)
  1. Recommendation to simultaneous vaccination and combined vaccines

    A survey will be used to evaluate the attitudes and recommendation behaviors among vaccination staff towards optimized vaccine scheduling strategies including simultaneous vaccination and combination vaccines. The outcome variable will be recommendation behavior, assessed on a 5-point Likert scale ranging from "strongly recommend" to "strongly not recommend". To examine the perceived difficulty of vaccine scheduling, the survey will collect potential contributing factors: complexity of immunization schedules, inaccuracy of manual scheduling, limited implementation of simultaneous vaccination strategies, insufficient use of combination vaccines, high demand for catch-up vaccination, and lack of clear guidance for non-NIP vaccines.

    Measured: 2025.08-2025.09

  2. Vaccine hesitancy

    Questions were designed in the questionnaire to evaluate the degree of vaccine hesitancy of interviewees. Respondents will be asked abound their confidence, convenience and complacency about vaccination of different non-NIP vaccines, so as to further explore the influencing factors of people's vaccination behaviors.

    Measured: 2025.08-2025.09

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2025
  2. Study start25 Aug 2025 (estimated)
  3. Primary completion30 Oct 2025 (estimated)
  4. Study completion30 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
6,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07141875
Sponsor's protocol ID
IRB00001052-25094
Status last verified
Aug 2025
First submitted
15 Aug 2025
Last updated
26 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Vaccination Behavior, run by Peking University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The economic value of optimized vaccination scheduling strategies (time frame: 2025.08-2025.09). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in